equityflowunderstand the flow and follow it
EquityFlowCompanies › Molmir

Molmir

Biotech · JP

Drug discovery platform that visualizes molecular dynamics (CHEmir, MAGmir) for previously intractable targets.

In the network

Shares the most investors with (number = shared investors):

Funding history

DateRoundAmount
Apr 2026Series A
Molmir raised 300 million yen in Series A funding from UntroD, Mitsubishi UFJ Capital and others for its molecular dynamics analysis platform and the TDP-43 program.
$1.9M

Investors

Tap an investor to see what else they have backed.

Other companies in Biotech

Other companies in JP

Other companies at Series A stage

Explore funding flow on EquityFlow →

Data is community-curated and may be incomplete.